MIFEPRISTONE
Generic: MIFEPRISTONE
Actavis PharmaManufacturer
ORALRoute
MIFEPRISTONEActive Substance
2020-08-03Original Approval
MIFEPRISTONE is FDA application ANDA211436, sponsored by TEVA PHARMS USA INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
HAEMORRHAGE
343 reports
2
ABORTION INCOMPLETE
335 reports
3
OFF LABEL USE
150 reports
4
PREGNANCY
118 reports
5
NAUSEA
115 reports
6
VOMITING
111 reports
7
ANAEMIA
105 reports
8
PAIN
95 reports
9
DIZZINESS
92 reports
10
MATERNAL EXPOSURE DURING PREGNANCY
88 reports